Upgrade to SI Premium - Free Trial

Goldman Sachs Downgrades ResMed (RMD:AU) (RMD) to Neutral

January 25, 2019 7:01 AM
Goldman Sachs analyst Chris Cooper downgraded ResMed (RMD:AU) (NYSE: RMD) from Buy to Neutral with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change Downgrades Intl Ratings

Next Articles